Here is how Adma Biologics (ADMA) and ResMed (RMD) have performed compared to their sector so far this year.
ADMA Biologics ( NASDAQ:ADMA ) First Quarter 2024 Results Key Financial Results Revenue: US$81.9m (up 44% from 1Q...
ADMA Biologics, Inc. (NASDAQ:ADMA) Q1 2024 Earnings Call Transcript May 9, 2024 ADMA Biologics, Inc. beats earnings expectations. Reported EPS is $0.07532, expectations were $0.05. ADMA isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon, and welcome to the […]